EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis

Gregory Ducrocq, Marine Cachanado, Tabassome Simon, Etienne Puymirat, Gilles Lemesle, Benoit Lattuca, Albert Ariza-Solé, Johanne Silvain, Emile Ferrari, Jose R Gonzalez-Juanatey, Manuel Martínez-Sellés, Thibault Lermusier und 7 weitere

Canadian Journal of Cardiology · 2024

DOI: 10.1016/j.cjca.2024.02.013 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Canadian Journal of Cardiology, 2024. Verfasst von Gregory Ducrocq und 18 weiteren Autor:innen. Beteiligte Einrichtung: Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), French Alliance for Cardiovascular Trials (FACT), INSERM U1148, Paris, France. Hauptthemen laut MEDLINE: Heart Failure, Anemia, Myocardial Infarction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, France Ministry of Solidarity and Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Red blood cell transfusion can cause fluid overload. We evaluated the interaction between heart failure (HF) at baseline and transfusion strategy on outcomes in acute myocardial infarction (AMI). METHODS: We used data from the randomized REALITY trial. HF was defined as history of HF or Killip class > 1 at randomization. Primary outcome was major adverse cardiovascular events (MACE): composite of all-cause death, nonrecurrent AMI, stroke, or emergency revascularization prompted by ischemia at 30 days. RESULTS: Among 658 randomized patients, 311 (47.3%) had HF. Patients with HF had higher rates of MACE at 30 days and 1 year and higher rates of nonfatal new-onset HF. There was no interaction between HF and effect of randomized assignment on the primary outcome or nonfatal new-onset HF. A liberal transfusion strategy was associated with increased all-cause death at 30 days and at 1 year in patients with HF (Pinteraction = 0.009 and P = 0.049, respectively). The main numerical difference in cause of death between restrictive and liberal strategies was death by HF at 30 days (4 vs 11). CONCLUSIONS: HF is frequent in patients with AMI and anemia and is associated with higher risk of MACE (including all-cause death) and nonfatal new-onset HF. Although there was no interaction of HF with effect of transfusion strategy on MACE, a liberal transfusion strategy was associated with higher all-cause death that appears driven by a higher risk of early death caused by HF. CLINICAL TRIAL REGISTRATION: NCT02648113.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureAnemiaMyocardial InfarctionHumansFemaleMaleAgedMiddle AgedBlood TransfusionCause of DeathErythrocyte Transfusion

Autor:innen und Institutionen

  • Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), French Alliance for Cardiovascular Trials (FACT), INSERM U1148, Paris, France.
  • Department of Clinical Pharmacology and Clinical Research Platform of the East of Paris (URC-CRC-CRB), AP-HP, Hôpital St Antoine, Sorbonne-Université, French Alliance for Cardiovascular Trials (FACT), Paris, France.
  • Université de Paris, AP-HP, Hôpital Européen Georges Pompidou, French Alliance for Cardiovascular Trials (FACT), Paris, France.
  • Institut Cœur Poumon, Centre Hospitalier Universitaire de Lille, Faculté de Médecine de Lille, Université de Lille, French Alliance for Cardiovascular Trials (FACT), Institut Pasteur de Lille, Inserm U1011, F-59000 Lill…
  • Cardiology department, Nimes University Hospital, Montpellier University, Nimes, France.
  • Bellvitge University Hospital, Bioheart, Grup de Malalties Cardiovasculars, Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Förderung

  • Instituto de Salud Carlos III
  • France Ministry of Solidarity and Health

Zitieren

APA

Ducrocq, G., Cachanado, M., Simon, T., Puymirat, E., Lemesle, G., Lattuca, B., Ariza-Solé, A., Silvain, J., Ferrari, E., Gonzalez-Juanatey, J. R., Martínez-Sellés, M., Lermusier, T., Coste, P., Vanzetto, G., Cottin, Y., Dillinger, J. G., Calvo, G., Steg, P. G., & REALITY Investigators (2024). Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2024.02.013

Vancouver

Ducrocq G, Cachanado M, Simon T, Puymirat E, Lemesle G, Lattuca B, et al. Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis. Canadian Journal of Cardiology. 2024. doi:10.1016/j.cjca.2024.02.013

BibTeX
@article{Ducrocq2024,
  author = {Ducrocq, Gregory and Cachanado, Marine and Simon, Tabassome and Puymirat, Etienne and Lemesle, Gilles and Lattuca, Benoit and Ariza-Solé, Albert and Silvain, Johanne and Ferrari, Emile and Gonzalez-Juanatey, Jose R and Martínez-Sellés, Manuel and Lermusier, Thibault and Coste, Pierre and Vanzetto, Gerald and Cottin, Yves and Dillinger, Jean G and Calvo, Gonzalo and Steg, Philippe Gabriel and REALITY Investigators, REALITY Investigators},
  title = {Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis},
  journal = {Canadian Journal of Cardiology},
  year = {2024},
  doi = {10.1016/j.cjca.2024.02.013}
}
Kostenlos starten →